Literature DB >> 18071941

Engineering antibodies for stability and efficient folding.

A Honegger1.   

Abstract

Antibody variable domains vary widely in their intrinsic thermodynamic stability. Despite the mutual stabilization of the domains in the scFv fragment, most scFv derived from monoclonal antibodies without further engineering show poor to moderate stability. The situation gets more complex for Fab fragments and full-sized antibodies: while the disulfide-linked C(L)/C(H) heterodimer shows very limited thermodynamic stability, its unfolding kinetics are very slow. The same is true for Fab fragments, which, due to this kinetic stabilization, appear to be more stable than their thermodynamic stability suggests. However, suboptimal variable domains can be engineered for improved stability and folding efficiency while preserving their antigen-binding specificity and affinity, either by a limited number of point mutations or by grafting their antigen specificity to superior variable domain frameworks.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18071941     DOI: 10.1007/978-3-540-73259-4_3

Source DB:  PubMed          Journal:  Handb Exp Pharmacol        ISSN: 0171-2004


  18 in total

Review 1.  Molecular engineering of antibodies for therapeutic and diagnostic purposes.

Authors:  Frédéric Ducancel; Bruno H Muller
Journal:  MAbs       Date:  2012-07-01       Impact factor: 5.857

Review 2.  Advances in Antibody Design.

Authors:  Kathryn E Tiller; Peter M Tessier
Journal:  Annu Rev Biomed Eng       Date:  2015-08-14       Impact factor: 9.590

3.  Improving the Accuracy of Protein Thermostability Predictions for Single Point Mutations.

Authors:  Jianxin Duan; Dmitry Lupyan; Lingle Wang
Journal:  Biophys J       Date:  2020-05-29       Impact factor: 4.033

4.  Identifying bottlenecks in transient and stable production of recombinant monoclonal-antibody sequence variants in Chinese hamster ovary cells.

Authors:  Megan Mason; Bernadette Sweeney; Katharine Cain; Paul Stephens; Susan T Sharfstein
Journal:  Biotechnol Prog       Date:  2012-05-21

5.  Strong and oriented immobilization of single domain antibodies from crude bacterial lysates for high-throughput compatible cost-effective antibody array generation.

Authors:  Klervi Even-Desrumeaux; Daniel Baty; Patrick Chames
Journal:  Mol Biosyst       Date:  2010-09-21

6.  Humanization of a mouse monoclonal antibody directed against a cell surface-exposed epitope of membrane-associated heat shock protein 70 (Hsp70).

Authors:  Kirstin A Zettlitz; Julia Seitter; Dafne Müller; Roland E Kontermann
Journal:  Mol Biotechnol       Date:  2010-11       Impact factor: 2.695

7.  Physical instability of a therapeutic Fc fusion protein: domain contributions to conformational and colloidal stability.

Authors:  Jonas L Fast; Amanda A Cordes; John F Carpenter; Theodore W Randolph
Journal:  Biochemistry       Date:  2009-12-15       Impact factor: 3.162

8.  A dual-targeting PDGFRbeta/VEGF-A molecule assembled from stable antibody fragments demonstrates anti-angiogenic activity in vitro and in vivo.

Authors:  Robert Mabry; Debra G Gilbertson; Amanda Frank; Tuyen Vu; Dan Ardourel; Craig Ostrander; Brenda Stevens; Susan Julien; Secil Franke; Brent Meengs; Jennifer Brody; Scott Presnell; Nels B Hamacher; Megan Lantry; Anitra Wolf; Tom Bukowski; Robert Rosler; Cindy Yen; Monica Anderson-Haley; Kenneth Brasel; Qi Pan; Hank Franklin; Penny Thompson; Mike Dodds; Sara Underwood; Scott Peterson; Pallavur V Sivakumar; Mark Snavely
Journal:  MAbs       Date:  2010-01-02       Impact factor: 5.857

9.  Vector-mediated gene transfer engenders long-lived neutralizing activity and protection against SIV infection in monkeys.

Authors:  Philip R Johnson; Bruce C Schnepp; Jianchao Zhang; Mary J Connell; Sean M Greene; Eloisa Yuste; Ronald C Desrosiers; K Reed Clark
Journal:  Nat Med       Date:  2009-05-17       Impact factor: 53.440

10.  Strategies for successful recombinant expression of disulfide bond-dependent proteins in Escherichia coli.

Authors:  Ario de Marco
Journal:  Microb Cell Fact       Date:  2009-05-14       Impact factor: 5.328

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.